GSK wins second Zantac cancer case to go to trial

GSK was found not liable in the second jury trial involving the company’s heartburn medication, Zantac.

The company said in a

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cognetivity Neurosciences Announces Collaboration with Alzheimer’s Society to Further Expand its AI Algorithms | Psychedelic Finance

Vancouver, British Columbia–(Newsfile Corp. – May 31, 2023) – Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (“the Company” or “Cognetivity”), a leading provider

June 9, 2023

Opinion | Closing Gender-Based Disease Disparities Starts in the Lab

Despite the fact men have lower life expectancy than women and are at a higher risk of developing serious health conditions like heart disease and

April 28, 2024

Gene variant predicts cognitive decline after stroke

New research led by UCLA Health has found that specific genes may be related to the trajectory of recovery for stroke survivors, providing doctors insights

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.